# Minimizing Pain During Office Intradetrussor Botox Injection

> **NCT04270526** · PHASE4 · COMPLETED · sponsor: **Boston Urogynecology Associates** · enrollment: 85 (actual)

## Conditions studied

- Overactive Bladder
- Overactive Detrusor
- Overactive Bladder Syndrome
- Overactivity; Behavior
- Urge Incontinence

## Interventions

- **DRUG:** Bicarbonate protocol
- **DRUG:** Standard protocol

## Key facts

- **NCT ID:** NCT04270526
- **Lead sponsor:** Boston Urogynecology Associates
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-15
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270526, "Minimizing Pain During Office Intradetrussor Botox Injection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04270526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*